IMVT logo

IMVT

Immunovant, Inc.NASDAQHealthcare
$24.50-2.39%ClosedMarket Cap: $4.99B

As of 2026-04-06

Insider Statistics (Q2 2026)

Purchases

1

Sales

4

Buy/Sell Ratio

0.25

Total Bought

$0.00

Total Sold

$2.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri Apr 03Venker Ericdirector, officer: Chief Executive OfficerSell368,750$14.461,106,250
Fri Apr 03Venker Ericdirector, officer: Chief Executive OfficerSell1,409$24.6019,561
Fri Apr 03Venker Ericdirector, officer: Chief Executive OfficerSell12,820$24.0420,970
Fri Apr 03Venker Ericdirector, officer: Chief Executive OfficerSell334,960$25.1033,790
Fri Mar 20Van Tuyl Christopherofficer: Chief Legal OfficerSell2,877$24.97147,053
Fri Feb 27Gloria Melanieofficer: Chief Operating OfficerSell942$28.90170,273
Fri Feb 27Gloria Melanieofficer: Chief Operating OfficerSell1,437$26.98172,074
Fri Feb 27Gloria Melanieofficer: Chief Operating OfficerSell859$28.16171,215
Fri Jan 23Stout Jay Sofficer: Chief Technology OfficerSell1,977$26.03197,634
Fri Jan 09Stout Jay Sofficer: Chief Technology OfficerSell1,148$26.51199,666
Fri Jan 09Stout Jay Sofficer: Chief Technology OfficerSell55$26.92199,611
Fri Dec 19Van Tuyl Christopherofficer: Chief Legal OfficerSell2,284$27.38149,930
Fri Dec 19Van Tuyl Christopherofficer: Chief Legal OfficerSell8,529$26.78152,214
Fri Dec 12Roivant Sciences Ltd.director, 10 percent owner: Buy16,666,666$21.00113,317,007